Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes
出版年份 2013 全文链接
标题
Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 8, Issue 3, Pages 319-330
出版商
Informa Healthcare
发表日期
2013-01-07
DOI
10.1517/17460441.2013.748744
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glucokinase activators as potential antidiabetic agents possessing superior glucose lowering efficacies
- (2015) M.C.T. Fyfe et al. DRUGS OF THE FUTURE
- Glucokinase Activators AZD6370 and AZD1656 Do Not Affect the Central Counterregulatory Response to Hypoglycemia in Healthy Males
- (2012) Ensio Norjavaara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetes in numbers
- (2012) Tony Scully NATURE
- The Expression and Function of Organic Anion Transporting Polypeptides in Normal Tissues and in Cancer
- (2011) Amanda Obaidat et al. Annual Review of Pharmacology and Toxicology
- Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
- (2011) G. E. Meininger et al. DIABETES CARE
- Discovery of (S)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus
- (2011) Jeffrey A. Pfefferkorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Involvement of Organic Anion Transporting Polypeptide in the Hepatic Uptake of Telmisartan in Rats: PET Studies with [11C]Telmisartan
- (2011) Tadayuki Takashima et al. MOLECULAR PHARMACEUTICS
- Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus
- (2011) Jeffrey A. Pfefferkorn et al. MedChemComm
- Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: A bench-to-bedside case study on tissue selective drug distribution
- (2010) Jeffrey A. Pfefferkorn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel glucokinase activators: a patent review (2008 – 2010)
- (2010) Ramakanth Sarabu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Glucokinase-activating GCKR Polymorphisms Increase Plasma Levels of Triglycerides and Free Fatty Acids, but do not Elevate Cardiovascular Risk in the Ludwigshafen Risk and Cardiovascular Health Study
- (2010) D. H. Kozian et al. HORMONE AND METABOLIC RESEARCH
- Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study
- (2010) Riccardo C. Bonadonna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Modelling and PBPK Simulation in Drug Discovery
- (2009) Hannah M. Jones et al. AAPS Journal
- The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
- (2009) Nicola L. Beer et al. HUMAN MOLECULAR GENETICS
- Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes
- (2009) Gregory R. Bebernitz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessing the potential of glucokinase activators in diabetes therapy
- (2009) Franz M. Matschinsky NATURE REVIEWS DRUG DISCOVERY
- Glucokinase and molecular aspects of liver glycogen metabolism
- (2008) Loranne Agius BIOCHEMICAL JOURNAL
- Molecular Physiology of Mammalian Glucokinase
- (2008) P. B. Iynedjian CELLULAR AND MOLECULAR LIFE SCIENCES
- Restoration of Hepatic Glucokinase Expression Corrects Hepatic Glucose Flux and Normalizes Plasma Glucose in Zucker Diabetic Fatty Rats
- (2008) T. P. Torres et al. DIABETES
- Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor
- (2008) R. Murphy et al. DIABETOLOGIA
- New Drugs for Type 2 Diabetes Mellitus
- (2008) Andrew J Krentz et al. DRUGS
- Glucokinase activators in diabetes management
- (2008) Matthew Coghlan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discontinued drug in 2007: renal, endocrine and metabolic drugs
- (2008) Jerry R Colca EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Glucokinase activators as new type 2 diabetes therapeutic agents
- (2008) Ramakanth Sarabu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started